X4 Pharmaceuticals: Q2 Earnings Snapshot

August 4, 2022 GMT

BOSTON (AP) _ X4 Pharmaceuticals, Inc. (XFOR) on Thursday reported a loss of $21.2 million in its second quarter.

The Boston-based company said it had a loss of 60 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 65 cents per share.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XFOR at https://www.zacks.com/ap/XFOR